Medical Devices

Request for TOC Request for Sample
BUY NOW

Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Devices Market – Industry Trends and Forecast to 2028

Medical Devices | Published Report | Sep 2021 | MEA | 350 Pages | No of Tables: 86 | No of Figures: 48

Report Description

The Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Devices Market, By Product Type (Endotherapy Devices, Endoscopes, Imaging Devices, and Others), Modality (Single Use, Standalone, Handheld), Procedure (Biliary Sphicterectomy, Biliary Stenting, Biliary Dilation, Pancreatic Duct Stenting, Pancreatic Sphicterectomy), Application (Bile Duct, Pancreas, Gall Bladder, Liver and Others), End User(Hospitals, Ambulatory Surgical Center, Diagnostic Laboratories and Others), Facility Type (Large, Medium and Small), Distribution Channel (Direct Tenders, Third Party Distribution, and Retail Sales), Country (South Africa, Saudi Arabia, UAE, Egypt, Kuwait, Israel and Rest of the Middle East and Africa) Industry Trends and Forecast 2028.

Get Exclusive Sample Copy of this Report Here

Market Analysis and Insights: Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Devices Market 

The Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is expected to grow in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.0% in the forecast period of 2021 to 2028 and is expected to reach USD 103.28 million by 2028 from USD 78.44 million in 2020. The high prevalence of pancreatic and biliary diseases is likely to be the major drivers that propel the market's demand in the forecast period.

The high prevalence of chronic diseases, pancreatic tumor, rising government expenditure on healthcare infrastructure, favourable reimbursement scenario are the driving the market growth. However, the stringent government rules for approval of devices are restraining the growth of the market. The rising awareness among people for early diagnosis and treatment of disease is acting as opportunity for the market. The side effects associated with ERCP procedure is acting as challenge for the market.

The Middle East and Africa endoscopic retrograde cholangiopancreatography devices market report provides details of market share, new developments, and impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.

Get Exclusive Sample Copy of this Report Here

The Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Devices Market Scope and Market Size

The Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is categorized into seven notable segments based on product type, modality, procedure, application, end user, facility type, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product type, the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is segmented into endotherapy devices, endoscopes, imaging devices, and others. In 2021, the endotherapy devices segment is expected to dominate the market due to the availability of various types of equipment. Big players are manufacturing this equipment in the Middle East and Africa market.
  • On the basis of modality, the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is segmented into single-use, standalone, and handheld. In 2021, the single-use segment is expected to dominate the market because there is no risk of disease transmission from one patient to another while using single-use devices.
  • On the basis of procedure, the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is segmented into biliary sphincterotomy, biliary stenting, biliary dilation, pancreatic duct stenting, and pancreatic sphincterotomy. In 2021, the biliary sphincterotomy segment is expected to dominate the market because of the high prevalence of pancreatic tumors in the Middle East and Africa region.
  • On the basis of application, the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is segmented into the bile duct, pancreas, gall bladder, liver, and others. In 2021, the bile duct segment is expected to dominate the market because of the high prevalence of biliary diseases in the Middle East and Africa region.
  • On the basis of end user, the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is segmented into hospitals, ambulatory surgical centers, diagnostic laboratories, and others. In 2021, the hospital's segment is expected to dominate the market due to the growing emphasis on strategic initiatives (such as acquisitions, partnerships, and collaborations) by medical device companies to expand their capabilities in the ERCP market.
  • On the basis of facility type, the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is segmented into large, medium, and small. In 2021, the large segment is expected to dominate the market due to the high demand for ERCP procedures in the Middle East and Africa.
  • On the basis of distribution channel, the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is segmented into direct tenders, third-party distribution, and retail sales. In 2021, the direct tender segment is expected to dominate the market because of significant growth due to the overall control over sales and revenue processes and direct interactions with customers.

The Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Devices Market Country Level Analysis

The Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is analyzed, and market size information is provided by product type, modality, procedure, applications, end-user, facility type, and distribution channel.

The countries covered in the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market report are South Africa, Saudi Arabia, UAE, Egypt, Kuwait, Israel, and the Rest of the Middle East and Africa.

The Middle East and Africa are expected to grow with a CAGR of 4.0% in the forecasted periods as in the Middle East and African countries; the high prevalence of biliary diseases and government support. South Africa is expected to dominate in the market in the Middle East and Africa market. South Africa is one of the leading countries to inculcate the endoscopic retrograde cholangiopancreatography devices market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of the Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data. 

The Presence of Advanced Technology and Strategic Initiatives Taken by Players are Creating New Opportunities in the Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Devices Market 

The Middle East and Africa endoscopic retrograde cholangiopancreatography devices market also provides you with detailed market analysis for every country's growth in a particular industry with ERCP products sales, the impact of advancement in the market, and changes in regulatory scenarios with their support for the market. The data is available for the historical period 2010 to 2019.

Competitive Landscape of the Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Devices Market Share Analysis

The Middle East and Africa endoscopic retrograde cholangiopancreatography devices market competitive landscape provide details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points are only related to the company's focus on the endoscopic retrograde cholangiopancreatography devices market.

The major companies providing the Middle East and Africa endoscopic retrograde cholangiopancreatography devices are Olympus Corporation, Boston Scientific Corporation, Medtronic, BD, Ambu Inc., CONMED Corporation, FUJIFILM Corporation, TeleMed Systems, Inc., Merit Medical Systems, Cook, KARL STORZ SE & Co. KG, Johnson & Johnson Services, Inc., HOYA Corporation, STERIS, Shaili Endoscopy, Hospiline Equipments among others.

DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The strategic initiatives by market players and new technological advancements for endoscopic retrograde cholangiopancreatography devices are bridging the gap for a variety of treatments.

For instance,

  • In December 2017, BD has completed the acquisition of C. R. Bard, Inc. This has helped strengthening B.D.’s business and accelerate its growth trajectory, particularly in the long term, which is anticipated to enhance leadership in Africa
  • In December 2020, Johnson & Johnson Services, Inc. announced that it has participated in 39th annual J.P. Morgan Healthcare Conference. This helped the company to give the correct knowledge about their product and would help the company to further grow in coming years

Collaboration, joint ventures, and other strategies by the market player are enhancing the company market in the endoscopic retrograde cholangiopancreatography devices market, which also benefits the organization to improve their offering for the market.


SKU-

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEAR CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET END USER COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: REGIONAL SUMMARY

5.1 NORTH AMERICA

5.2 EUROPE

5.3 ASIA-PACIFIC

5.4 SOUTH AMERICA

5.5 MIDDLE EAST AND AFRICA

6 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: REGULATIONS

6.1 UNITED STATES

6.2 EUROPE

6.3 CHINA

6.4 AUSTRALIA

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 SURGE IN PREVALENCE OF PANCREATIC AND LIVER DISORDERS

7.1.2 INCREASE IN THE GERIATRIC POPULATION

7.1.3 RISING HEALTHCARE EXPENDITURE

7.1.4 HIGH PREVALENCE OF PANCREATIC CANCER

7.2 RESTRAINTS

7.2.1 HIGH COST OF DEVICES

7.2.2 STRINGENT GOVERNMENT RULES

7.2.3 EMERGENCE OF COVID-19

7.3 OPPORTUNITIES

7.3.1 STRATEGIC INITIATIVES TAKEN BY PLAYERS

7.3.2 RISE IN ALCOHOL CONSUMPTION AND SURGE IN SMOKING

7.3.3 RISING DISPOSABLE INCOME

7.3.4 GROWING MEDICAL TOURISM

7.4 CHALLENGES

7.4.1 COMPLICATIONS ASSOCIATED WITH PROCEDURE

7.4.2 SHORTAGE OF SKILLED PERSONNEL

8 IMPACT OF COVID-19 ON MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET

8.1 IMPACT ON PRICE

8.2 IMPACT ON DEMAND

8.3 IMPACT ON SUPPLY

8.4 KEY INITIATIVES BY MARKET PLAYER DURING COVID 19

8.5 CONCLUSION:

9 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE

9.1 OVERVIEW

9.2 ENDOTHERAPY DEVICES

9.2.1 SPHINCTEROTOME

9.2.2 CANNULAS

9.2.3 CATHETERS

9.2.4 BALLOONS

9.2.5 LITHOTRIPTERS

9.2.6 STENTS

9.2.7 GUIDING WIRES

9.2.8 FORCEPS

9.2.9 BASKETS

9.2.10 SNARES

9.2.11 OTHERS

9.3 ENDOSCOPE

9.4 IMAGING DEVICES

9.5 OTHERS

10 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY

10.1 OVERVIEW

10.2 SINGLE USE

10.3 STANDALONE

10.4 HANDHELD

11 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE

11.1 OVERVIEW

11.2 BILIARY SPHINCTERECTOMY

11.3 BILIARY STENTING

11.4 BILIARY DILATION

11.5 PANCREATIC DUCT STENTING

11.6 PANCREATIC DUCT DILATION

11.7 PANCREATIC SPHINCTERECTOMY

12 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION

12.1 OVERVIEW

12.2 BILE DUCT

12.3 PANCREAS

12.4 GALL BLADDER

12.5 LIVER

12.6 OTHERS

13 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER

13.1 OVERVIEW

13.2 HOSPITALS

13.3 AMBULATORY SURGICAL CENTERS

13.4 DIAGNOSTIC LABORATORIES

13.5 OTHERS

14 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE

14.1 OVERVIEW

14.2 LARGE

14.3 MEDIUM

14.4 SMALL

15 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL

15.1 OVERVIEW

15.2 DIRECT TENDERS

15.3 THIRD PARTY DISTRIBUTION

15.4 RETAIL SALES

16 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION

16.1 MIDDLE EAST AND AFRICA

16.1.1 SOUTH AFRICA

16.1.2 SAUDI ARABIA

16.1.3 U.A.E.

16.1.4 EGYPT

16.1.5 ISRAEL

16.1.6 REST OF MIDDLE EAST AND AFRICA

17 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: COMPANY LANDSCAPE

17.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

18 SWOT ANALYSIS

19 COMPANY PROFILE

19.1 OLYMPUS CORPORATION

19.1.1 COMPANY SNAPSHOT

19.1.2 REVENUE ANALYSIS

19.1.3 COMPANY SHARE ANALYSIS

19.1.4 PRODUCT PORTFOLIO

19.1.5 RECENT DEVELOPMENTS

19.2 BOSTON SCIENTIFIC CORPORATION

19.2.1 COMPANY SNAPSHOT

19.2.2 REVENUE ANALYSIS

19.2.3 COMPANY SHARE ANALYSIS

19.2.4 PRODUCT PORTFOLIO

19.2.5 RECENT DEVELOPMENTS

19.3 STERIS

19.3.1 COMPANY SNAPSHOT

19.3.2 REVENUE ANALYSIS

19.3.3 COMPANY SHARE ANALYSIS

19.3.4 PRODUCT PORTFOLIO

19.3.5 RECENT DEVELOPMENTS

19.4 FUJIFILM CORPORATION

19.4.1 COMPANY SNAPSHOT

19.4.2 REVENUE ANALYSIS

19.4.3 COMPANY SHARE ANALYSIS

19.4.4 PRODUCT PORTFOLIO

19.4.5 RECENT DEVELOPMENTS

19.5 BD

19.5.1 COMPANY SNAPSHOT

19.5.2 REVENUE ANALYSIS

19.5.3 COMPANY SHARE ANALYSIS

19.5.4 PRODUCT PORTFOLIO

19.5.5 RECENT DEVELOPMENTS

19.6 MEDTRONIC

19.6.1 COMPANY SNAPSHOT

19.6.2 REVENUE ANALYSIS

19.6.3 PRODUCT PORTFOLIO

19.6.4 RECENT DEVELOPMENTS

19.7 JOHNSON & JOHNSON SERVICES, INC.

19.7.1 COMPANY SNAPSHOT

19.7.2 REVENUE ANALYSIS

19.7.3 PRODUCT PORTFOLIO

19.7.4 RECENT DEVELOPMENTS

19.8 AMBU INC.

19.8.1 COMPANY SNAPSHOT

19.8.2 REVENUE ANALYSIS

19.8.3 PRODUCT PORTFOLIO

19.8.4 RECENT DEVELOPMENTS

19.9 CONMED CORPORATION

19.9.1 COMPANY SNAPSHOT

19.9.2 REVENUE ANALYSIS

19.9.3 PRODUCT PORTFOLIO

19.9.4 RECENT DEVELOPMENTS

19.1 COOK

19.10.1 COMPANY SNAPSHOT

19.10.2 PRODUCT PORTFOLIO

19.10.3 RECENT DEVELOPMENT

19.11 HOBBS MEDICAL INC.

19.11.1 COMPANY SNAPSHOT

19.11.2 PRODUCT PORTFOLIO

19.11.3 RECENT DEVELOPMENT

19.12 HOSPILINE EQUIPMENTS

19.12.1 COMPANY SNAPSHOT

19.12.2 PRODUCT PORTFOLIO

19.12.3 RECENT DEVELOPMENT

19.13 HOYA CORPORATION

19.13.1 COMPANY SNAPSHOT

19.13.2 REVENUE ANALYSIS

19.13.3 PRODUCT PORTFOLIO

19.13.4 RECENT DEVELOPMENT

19.14 KARL STORZ SE & CO. KG

19.14.1 COMPANY SNAPSHOT

19.14.2 PRODUCT PORTFOLIO

19.14.3 RECENT DEVELOPMENTS

19.15 MEDI-GLOBE GMBH

19.15.1 COMPANY SNAPSHOT

19.15.2 PRODUCT PORTFOLIO

19.15.3 RECENT DEVELOPMENT

19.16 MERIT MEDICAL SYSTEMS

19.16.1 COMPANY SNAPSHOT

19.16.2 REVENUE ANALYSIS

19.16.3 PRODUCT PORTFOLIO

19.16.4 RECENT DEVELOPMENT

19.17 SHAILI ENDOSCOPY

19.17.1 COMPANY SNAPSHOT

19.17.2 PRODUCT PORTFOLIO

19.17.3 RECENT DEVELOPMENT

19.18 TELEMED SYSTEMS, INC.

19.18.1 COMPANY SNAPSHOT

19.18.2 PRODUCT PORTFOLIO

19.18.3 RECENT DEVELOPMENT

20 QUESTIONNAIRE

21 RELATED REPORTS

List of Table

TABLE 1 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 2 MIDDLE EAST AND AFRICA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 3 MIDDLE EAST AND AFRICA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 4 MIDDLE EAST AND AFRICA ENDOSCOPE IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 MIDDLE EAST AND AFRICA IMAGING DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 MIDDLE EAST AND AFRICA OTHERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA SINGLE USE IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA STANDALONE IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA HANDHELD IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA BILIARY SPHINCTERECTOMY IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA BILIARY STENTING IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA BILIARY DILATION IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA PANCREATIC DUCT STENTING IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA PANCREATIC DUCT DILATION IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA PANCREATIC SPHINCTERECTOMY IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA BILE DUCT IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA PANCREAS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA GALL BLADDER IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA LIVER IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA OTHERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA HOSPITALS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA AMBULATORY SURGICAL CENTERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA DIAGNOSTIC LABORATORIES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA OTHERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA LARGE IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA MEDIUM IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA SMALL IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA DIRECT TENDERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA THIRD PARTY DISTRIBUTION IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA RETAIL SALES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 44 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)

TABLE 45 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 46 SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 47 SOUTH AFRICA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 48 SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 49 SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 50 SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 51 SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 52 SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)

TABLE 53 SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 54 SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 55 SAUDI ARABIA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 56 SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 57 SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 58 SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 59 SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 60 SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)

TABLE 61 SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 62 U.A.E. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 63 U.A.E. ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 64 U.A.E. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 65 U.A.E. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 66 U.A.E. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 67 U.A.E. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 68 U.A.E. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)

TABLE 69 U.A.E. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 70 EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 71 EGYPT ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 72 EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 73 EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 74 EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 75 EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 76 EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)

TABLE 77 EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 78 ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 79 ISRAEL ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 80 ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 81 ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 82 ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 83 ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 84 ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)

TABLE 85 ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 86 REST OF MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

List of Figure

FIGURE 1 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET : MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET : COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: MARKET END USER COVERAGE GRID

FIGURE 9 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: SEGMENTATION

FIGURE 11 THE HIGH PREVALENCE OF PANCREATIC AND BILIARY DISEASES IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 ENDOTHERAPY DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET IN 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET

FIGURE 14 PANCREATIC CANCER MORTALITY, BY REGION (2020)

FIGURE 15 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, 2020

FIGURE 16 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, 2021-2028 (USD MILLION)

FIGURE 17 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, CAGR (2021-2028)

FIGURE 18 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 19 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, 2020

FIGURE 20 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, 2021-2028 (USD MILLION)

FIGURE 21 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, CAGR (2021-2028)

FIGURE 22 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, LIFELINE CURVE

FIGURE 23 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, 2020

FIGURE 24 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, 2021-2028 (USD MILLION)

FIGURE 25 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, CAGR (2021-2028)

FIGURE 26 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, LIFELINE CURVE

FIGURE 27 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, 2020

FIGURE 28 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, 2021-2028 (USD MILLION)

FIGURE 29 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 30 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 31 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, 2020

FIGURE 32 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, 2021-2028 (USD MILLION)

FIGURE 33 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, CAGR (2021-2028)

FIGURE 34 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, LIFELINE CURVE

FIGURE 35 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, 2020

FIGURE 36 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, 2021-2028 (USD MILLION)

FIGURE 37 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, CAGR (2021-2028)

FIGURE 38 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, LIFELINE CURVE

FIGURE 39 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 40 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

FIGURE 41 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 42 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 43 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: SNAPSHOT (2020)

FIGURE 44 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY COUNTRY (2020)

FIGURE 45 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY COUNTRY (2021 & 2028)

FIGURE 46 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY COUNTRY (2020 & 2028)

FIGURE 47 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE (2021-2028)

FIGURE 48 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: COMPANY SHARE 2020 (%)

View Infographics

FIGURE 1 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET : MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET : COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: MARKET END USER COVERAGE GRID

FIGURE 9 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: SEGMENTATION

FIGURE 11 THE HIGH PREVALENCE OF PANCREATIC AND BILIARY DISEASES IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 ENDOTHERAPY DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET IN 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET

FIGURE 14 PANCREATIC CANCER MORTALITY, BY REGION (2020)

FIGURE 15 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, 2020

FIGURE 16 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, 2021-2028 (USD MILLION)

FIGURE 17 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, CAGR (2021-2028)

FIGURE 18 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 19 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, 2020

FIGURE 20 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, 2021-2028 (USD MILLION)

FIGURE 21 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, CAGR (2021-2028)

FIGURE 22 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, LIFELINE CURVE

FIGURE 23 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, 2020

FIGURE 24 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, 2021-2028 (USD MILLION)

FIGURE 25 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, CAGR (2021-2028)

FIGURE 26 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, LIFELINE CURVE

FIGURE 27 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, 2020

FIGURE 28 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, 2021-2028 (USD MILLION)

FIGURE 29 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 30 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 31 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, 2020

FIGURE 32 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, 2021-2028 (USD MILLION)

FIGURE 33 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, CAGR (2021-2028)

FIGURE 34 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, LIFELINE CURVE

FIGURE 35 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, 2020

FIGURE 36 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, 2021-2028 (USD MILLION)

FIGURE 37 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, CAGR (2021-2028)

FIGURE 38 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, LIFELINE CURVE

FIGURE 39 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 40 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

FIGURE 41 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 42 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 43 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: SNAPSHOT (2020)

FIGURE 44 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY COUNTRY (2020)

FIGURE 45 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY COUNTRY (2021 & 2028)

FIGURE 46 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY COUNTRY (2020 & 2028)

FIGURE 47 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE (2021-2028)

FIGURE 48 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: COMPANY SHARE 2020 (%)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 8500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19